Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelZygoma 45 37.5mm: medical device reports filed with FDA

351 reports name it, 2019–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

351
device reports naming the brand
0% of all MAUDE reports · about 51 a year
52
reports, 12 months to August 2026
44 in the 12 months before
1.1%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 351 reports that name the brand "NobelZygoma 45 37.5mm" (endosseous dental implant), received between September 2019 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

52 reports arrived in the 12 months to August 2026, up 18% from 44 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.9%) and malfunction (1.1%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (58.7%), loss of osseointegration (19.1%) and osseointegration problem (8.5%). The patient problems coded most often are failure of implant, pain and numbness. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0918Sep 2021: 8Oct 2021: 2Nov 2021: 4Dec 2021: 22022Jan 2022: 6Feb 2022: 2Mar 2022: 14Apr 2022: 2May 2022: 10Jun 2022: 6Jul 2022: 6Aug 2022: 4Sep 2022: 0Oct 2022: 4Nov 2022: 8Dec 2022: 102023Jan 2023: 8Feb 2023: 6Mar 2023: 6Apr 2023: 2May 2023: 12Jun 2023: 6Jul 2023: 6Aug 2023: 8Sep 2023: 6Oct 2023: 6Nov 2023: 4Dec 2023: 02024Jan 2024: 2Feb 2024: 6Mar 2024: 4Apr 2024: 2May 2024: 6Jun 2024: 2Jul 2024: 2Aug 2024: 2Sep 2024: 6Oct 2024: 2Nov 2024: 0Dec 2024: 22025Jan 2025: 2Feb 2025: 4Mar 2025: 2Apr 2025: 0May 2025: 0Jun 2025: 2Jul 2025: 18Aug 2025: 6Sep 2025: 2Oct 2025: 4Nov 2025: 6Dec 2025: 02026Jan 2026: 0Feb 2026: 6Mar 2026: 6Apr 2026: 0May 2026: 10Jun 2026: 12Jul 2026: 2Aug 2026: 4

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

036722019: 1420192020: 2520202021: 4820212022: 7220222023: 7020232024: 3620242025: 4620252026: 402026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.9%347
Malfunction1.1%4
Other0%0
Not given0%0

Who filed the report

Manufacturer report51%179
Voluntary report0%0
User facility report0%0
Distributor report49%172
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate20658.7%62.8%
Loss of osseointegration6719.1%22.4%
Osseointegration problem308.5%7.7%
Fracturea broken bone164.6%1.6%
Patient device interaction problem82.3%0.3%
Insufficient device problem information41.1%0.2%
Device markings/labelling problema problem with the device markings or label20.6%0%
Difficult to insertthe device was hard to insert20.6%0.4%
Difficult to removethe device was hard to remove20.6%0%
Material deformation20.6%0.1%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant26174.4%
Painpain, site not specified4613.1%
Numbnessnumbness185.1%
Fistula41.1%
Abscessa collection of pus20.6%
Appropriate clinical signs, symptoms and conditions term/code not available20.6%
Bone fracture(s)20.6%
Sinus perforation20.6%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelZygoma 45 37.5mmProduct code DZEAll MAUDE reports
Reports3513,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.9%99.2%36.2%
Classified as malfunction1.1%0.8%62.3%
Filed by the manufacturer51%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelZygoma 45 37.5mm reports

How many FDA reports name NobelZygoma 45 37.5mm?

351 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 52 in the latest 12 months.

What kinds of events are reported?

injury (98.9%) and malfunction (1.1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (58.7%), loss of osseointegration (19.1%), osseointegration problem (8.5%), fracture (4.6%) and patient device interaction problem (2.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (51%) and distributor reports (49%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelZygoma 45 37.5mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.